{"id":4839,"date":"2021-10-15T00:00:00","date_gmt":"2022-10-14T16:14:58","guid":{"rendered":"https:\/\/mdbc1.wpengine.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/"},"modified":"2023-05-02T08:21:27","modified_gmt":"2023-05-02T12:21:27","slug":"evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement","status":"publish","type":"eb_course","link":"http:\/\/www.mdbriefcase.com\/fr\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/","title":{"rendered":"\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement)"},"content":{"rendered":"<p><strong>Le contenu de ce cours est disponible uniquement en anglais.<\/strong><strong><\/strong><\/p>\n<p>L\u2019immunoth\u00e9rapie a apport\u00e9 d\u2019importantes avanc\u00e9es en oncologie, \u00e9largissant les options de traitement et offrant des bienfaits cliniques d\u00e9montr\u00e9s dans de nombreux types de cancer.\n<\/p>\n<p>Dans le cas du cancer du poumon non \u00e0 petites cellules (CPNPC), les th\u00e9rapies sont en pleine \u00e9volution et les options disponibles augmentent, suite \u00e0 la publication des r\u00e9sultats tir\u00e9s d\u2019\u00e9tudes cliniques cl\u00e9s. L\u2019analyse du biomarqueur PD-L1 a \u00e9t\u00e9 largement valid\u00e9 et sert de cible th\u00e9rapeutique dans ce type de cancer.\n<\/p>\n<p>Dans le cas du m\u00e9soth\u00e9liome pleural malin (MPM) non-r\u00e9s\u00e9cable non pr\u00e9alablement trait\u00e9, l\u2019association nivolumab plus ipilimumab est le seul traitement d\u2019immunoth\u00e9rapie approuv\u00e9 par Sant\u00e9 Canada.\n<\/p>\n<p>      Ce programme explore les bienfaits et les limites des options immuno-th\u00e9rapeutiques et fait \u00e9tat des \u00e9tudes cliniques importantes qui ont inform\u00e9 et guid\u00e9 leur utilisation dans la prise en charge du CPNPC et du MPM.\n<\/p>\n<hr>\n<p>Ce programme de formation a fait l\u2019objet d\u2019une bourse \u00e0 vis\u00e9e \u00e9ducative ou d\u2019un soutien en nature de la part de BMS.<\/p>","protected":false},"featured_media":440677,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-4839","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement) - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement) - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Le contenu de ce cours est disponible uniquement en anglais. L\u2019immunoth\u00e9rapie a apport\u00e9 d\u2019importantes avanc\u00e9es en oncologie, \u00e9largissant les options de traitement et offrant des bienfaits cliniques d\u00e9montr\u00e9s dans de nombreux types de cancer. Dans le cas du cancer du poumon non \u00e0 petites cellules (CPNPC), les th\u00e9rapies sont en pleine \u00e9volution et les options [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T12:21:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Lung-Cancer-Webinar-20.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/\",\"name\":\"\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement) - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Lung-Cancer-Webinar-20.jpg\",\"datePublished\":\"2022-10-14T16:14:58+00:00\",\"dateModified\":\"2023-05-02T12:21:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Lung-Cancer-Webinar-20.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Lung-Cancer-Webinar-20.jpg\",\"width\":600,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement) - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/","og_locale":"fr_CA","og_type":"article","og_title":"\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement) - MDBriefCase","og_description":"Le contenu de ce cours est disponible uniquement en anglais. L\u2019immunoth\u00e9rapie a apport\u00e9 d\u2019importantes avanc\u00e9es en oncologie, \u00e9largissant les options de traitement et offrant des bienfaits cliniques d\u00e9montr\u00e9s dans de nombreux types de cancer. Dans le cas du cancer du poumon non \u00e0 petites cellules (CPNPC), les th\u00e9rapies sont en pleine \u00e9volution et les options [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/","og_site_name":"MDBriefCase","article_modified_time":"2023-05-02T12:21:27+00:00","og_image":[{"width":600,"height":338,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Lung-Cancer-Webinar-20.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/","url":"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/","name":"\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement) - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Lung-Cancer-Webinar-20.jpg","datePublished":"2022-10-14T16:14:58+00:00","dateModified":"2023-05-02T12:21:27+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Lung-Cancer-Webinar-20.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Lung-Cancer-Webinar-20.jpg","width":600,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/evolution-du-role-de-limmunotherapie-dans-le-mesotheliome-et-le-cpnpc-metastatique-en-anglais-seulement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"\u00c9volution du r\u00f4le de l\u2019immunoth\u00e9rapie dans le m\u00e9soth\u00e9liome et le CPNPC m\u00e9tastatique (en anglais seulement)"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/4839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=4839"}],"version-history":[{"count":0,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/4839\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/440677"}],"wp:attachment":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=4839"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=4839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}